Standardization of infusion solutions to reduce the risk of incompatibility

Nemec, Karin; Kopelent-Frank, Hannelore; Greif, Robert (2008). Standardization of infusion solutions to reduce the risk of incompatibility. American journal of health-system pharmacy, 65(17), pp. 1648-54. Bethesda, Md.: American Society of Health-System Pharmacists 10.2146/ajhp070471

Full text not available from this repository. (Request a copy)

PURPOSE: Although critically ill patients usually have various central intravenous (i.v.) lines, numerous drugs have to be infused simultaneously through the same lines. This can result in potentially harmful in-line incompatibility that can cause decreased drug effectiveness or increased microparticle load. To minimize the risk of these medication errors at an anesthesia intensive care unit (ICU), the preparation and administration of continuously infused drugs were standardized and the practicability in daily clinical routine was evaluated. SUMMARY: The concentration and diluent of continuously administered i.v. drugs were standardized. The drugs were grouped according to pH, medical indication, and chemical structure. The ICU staff decided to use multilumen central venous catheters, and each group of drugs was assigned to one lumen. Only drugs that belonged to the same group were infused simultaneously through the same lumen; therefore, intragroup incompatibilities had to be excluded before establishing the new drug administration plan at the ICU. The visual compatibility of 115 clinically reasonable intragroup drug mixtures was investigated. All drug combinations were compatible for six hours except mixtures containing thiopental, which was reassigned to a single-line use. In the following year, the practicability of this drug administration plan was evaluated. No deviations were found in the compliance of the staff prescribing and preparing only standardized concentrations and diluents. Further research to investigate the chemical compatibility of the drugs in these multiple mixtures will follow. CONCLUSION: A project intended to avoid incompatibility among i.v. drugs infused in the intensive care setting included steps to standardize solutions and determine which could be given together.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

Greif, Robert

ISSN:

1079-2082, 1535-2900

ISBN:

18714112

Publisher:

American Society of Health-System Pharmacists

Submitter:

Jeannie Wurz

Date Deposited:

04 Oct 2013 15:03

Last Modified:

05 Dec 2022 14:19

Publisher DOI:

10.2146/ajhp070471

PubMed ID:

18714112

Web of Science ID:

000258733500014

URI:

https://boris.unibe.ch/id/eprint/27274 (FactScience: 105863)

Actions (login required)

Edit item Edit item
Provide Feedback